Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
74
FHN Quote, Financials, Valuation and Earnings
Last price:
$24.12
Seasonality move
:
3.35%
Day range:
$24.07 - $24.72
52-week range:
$15.19 - $24.91
Dividend yield:
2.49%
P/E ratio:
12.85x
P/S ratio:
2.48x
P/B ratio:
1.38x
Volume:
11.6M
Avg. volume:
6.1M
1-year change:
13.19%
Market cap:
$11.7B
Revenue:
$5B
EPS (TTM):
$1.88
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $3.4B | $4.8B | $5B | $5B | |
| Revenue Growth (YoY) | -4.82% | 11.05% | 38.82% | 5.16% | -0.95% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $419M | $223M | $129M | $98M | -- | |
| Operating Expenses | -$1.2B | -$1.1B | -$886M | -$1B | -$1.3B | |
| Operating Income | $1.2B | $1.1B | $886M | $1B | $1.3B | |
| Net Interest Expenses | $77M | $77M | $212M | $109M | $108M | |
| EBT. Incl. Unusual Items | $1.3B | $1.2B | $1.1B | $1B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $274M | $247M | $212M | $211M | $282M | |
| Net Income to Company | $1B | $912M | $916M | $794M | -- | |
| Minority Interest in Earnings | $11M | $12M | $19M | $19M | $16M | |
| Net Income to Common Excl Extra Items | $1B | $912M | $916M | $794M | $999M | |
| Basic EPS (Cont. Ops) | $1.76 | $1.62 | $1.58 | $1.37 | $1.89 | |
| Diluted EPS (Cont. Ops) | $1.75 | $1.53 | $1.54 | $1.36 | $1.87 | |
| Weighted Average Basic Share | $546.4M | $535M | $548.4M | $540.3M | $505M | |
| Weighted Average Diluted Share | $551.2M | $566M | $561.7M | $544.3M | $511M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Revenue (Reported) | $3.1B | $3.4B | $4.8B | $5B | $5B | |
| Operating Income (Reported) | $1.2B | $1.1B | $886M | $1B | $1.3B | |
| Operating Income (Adjusted) | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $756M | $1B | $1.3B | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -6.26% | 36.38% | 22.6% | -8.07% | 8.61% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $83M | $35M | $31M | -$42M | -- | |
| Operating Expenses | -$274M | -$334M | -$176M | -$210M | -$342M | |
| Operating Income | $274M | $334M | $176M | $210M | $342M | |
| Net Interest Expenses | $18M | $22M | $22M | $43M | $24M | |
| EBT. Incl. Unusual Items | $281M | $334M | $178M | $210M | $343M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $52M | $64M | -$11M | $40M | $78M | |
| Net Income to Company | $229M | $270M | $189M | $170M | -- | |
| Minority Interest in Earnings | $2M | $4M | $5M | $4M | $4M | |
| Net Income to Common Excl Extra Items | $229M | $270M | $189M | $170M | $265M | |
| Basic EPS (Cont. Ops) | $0.41 | $0.48 | $0.31 | $0.30 | $0.52 | |
| Diluted EPS (Cont. Ops) | $0.40 | $0.45 | $0.31 | $0.29 | $0.52 | |
| Weighted Average Basic Share | $537M | $536M | $559M | $528M | $491M | |
| Weighted Average Diluted Share | $542M | $572M | $561M | $534M | $496M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $315M | $481M | $647M | $648M | $718M | |
| Revenue (Reported) | $756M | $1B | $1.3B | $1.2B | $1.3B | |
| Operating Income (Reported) | $274M | $334M | $176M | $210M | $342M | |
| Operating Income (Adjusted) | $315M | $481M | $647M | $648M | $718M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.5B | $4.8B | $5B | $5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $419M | $150M | $89M | $99M | -- | |
| Operating Expenses | -$1.3B | -$1.1B | -$879M | -$985M | -$1.3B | |
| Operating Income | $1.3B | $1.1B | $879M | $985M | $1.3B | |
| Net Interest Expenses | $76M | $84M | $261M | $198M | $131M | |
| EBT. Incl. Unusual Items | $1.3B | $1.2B | $1.1B | $1B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $274M | $247M | $213M | $211M | $283M | |
| Net Income to Company | $1B | $912M | $916M | $794M | -- | |
| Minority Interest in Earnings | $11M | $13M | $18M | $19M | $16M | |
| Net Income to Common Excl Extra Items | $1B | $913M | $915M | $794M | $998M | |
| Basic EPS (Cont. Ops) | $1.76 | $1.62 | $1.59 | $1.37 | $1.90 | |
| Diluted EPS (Cont. Ops) | $1.74 | $1.53 | $1.53 | $1.36 | $1.88 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Revenue (Reported) | $3.2B | $3.5B | $4.8B | $5B | $5B | |
| Operating Income (Reported) | $1.3B | $1.1B | $879M | $985M | $1.3B | |
| Operating Income (Adjusted) | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.5B | $4.8B | $5B | $5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $419M | $150M | $89M | $99M | $91M | |
| Operating Expenses | -$1.3B | -$1.1B | -$879M | -$985M | -$1.3B | |
| Operating Income | $1.3B | $1.1B | $879M | $985M | $1.3B | |
| Net Interest Expenses | $76M | $84M | $261M | $198M | $131M | |
| EBT. Incl. Unusual Items | $1.3B | $1.2B | $1.1B | $1B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $274M | $247M | $213M | $211M | $283M | |
| Net Income to Company | $1B | $912M | $916M | $794M | $467M | |
| Minority Interest in Earnings | $11M | $13M | $18M | $19M | $16M | |
| Net Income to Common Excl Extra Items | $1B | $913M | $915M | $794M | $998M | |
| Basic EPS (Cont. Ops) | $1.76 | $1.62 | $1.59 | $1.37 | $1.90 | |
| Diluted EPS (Cont. Ops) | $1.74 | $1.53 | $1.53 | $1.36 | $1.88 | |
| Weighted Average Basic Share | $2.2B | $2.1B | $2.2B | $2.2B | $2B | |
| Weighted Average Diluted Share | $2.2B | $2.3B | $2.3B | $2.2B | $2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Revenue (Reported) | $3.2B | $3.5B | $4.8B | $5B | $5B | |
| Operating Income (Reported) | $1.3B | $1.1B | $879M | $985M | $1.3B | |
| Operating Income (Adjusted) | $1.4B | $1.5B | $2.7B | $2.8B | $2.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $1.1B | $1B | $906M | $961M | |
| Short Term Investments | $8.7B | $8.8B | $8.4B | $6.5B | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.4B | $4.5B | $4.8B | $4.7B | $4.6B | |
| Property Plant And Equipment | $1B | $946M | $899M | $872M | $544M | |
| Long-Term Investments | $17.2B | $3.4B | $3.4B | $3.7B | $1.5B | |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.5B | -- | |
| Other Intangibles | $298M | $234M | $186M | $143M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $89.1B | $79B | $81.7B | $82.2B | $83.9B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $102M | $1.1B | $326M | $1B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $33.4B | $28.7B | $20.3B | $20B | $19.7B | |
| Long-Term Debt | $2B | $2B | $1.5B | $1.5B | $1.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.6B | $70.4B | $72.4B | $73B | $74.7B | |
| Common Stock | $333M | $336M | $349M | $328M | $303M | |
| Other Common Equity Adj | -$288M | -$1.4B | -$1.2B | -$1.1B | -- | |
| Common Equity | $7.7B | $7.2B | $8.5B | $8.4B | $8.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $295M | $295M | $295M | $295M | $295M | |
| Total Equity | $8.5B | $8.5B | $9.3B | $9.1B | $9.1B | |
| Total Liabilities and Equity | $89.1B | $79B | $81.7B | $82.2B | $83.9B | |
| Cash and Short Terms | $24.8B | $11.3B | $10.7B | $8.9B | -- | |
| Total Debt | $2B | $2B | $1.5B | $1.5B | $1.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $1.1B | $1B | $906M | $961M | |
| Short Term Investments | $8.7B | $8.8B | $8.4B | $6.5B | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $18.4B | $4.5B | $4.8B | $4.7B | $4.6B | |
| Property Plant And Equipment | $1B | $946M | $899M | $872M | $544M | |
| Long-Term Investments | $17.2B | $3.4B | $3.4B | $3.7B | $1.5B | |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.5B | -- | |
| Other Intangibles | $298M | $234M | $186M | $143M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $89.1B | $79B | $81.7B | $82.2B | $83.9B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $102M | $1.1B | $326M | $1B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $33.4B | $28.7B | $20.3B | $20B | $19.7B | |
| Long-Term Debt | $2B | $2B | $1.5B | $1.5B | $1.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.6B | $70.4B | $72.4B | $73B | $74.7B | |
| Common Stock | $333M | $336M | $349M | $328M | $303M | |
| Other Common Equity Adj | -$288M | -$1.4B | -$1.2B | -$1.1B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | $100M | -- | |
| Minority Interest, Total | $295M | $295M | $295M | $295M | $295M | |
| Total Equity | $8.5B | $8.5B | $9.3B | $9.1B | $9.1B | |
| Total Liabilities and Equity | $89.1B | $79B | $81.7B | $82.2B | $83.9B | |
| Cash and Short Terms | $24.8B | $11.3B | $10.7B | $8.9B | -- | |
| Total Debt | $2B | $2B | $1.5B | $1.5B | $1.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $857M | $1B | $912M | $916M | $794M | |
| Depreciation & Amoritzation | $92M | $117M | $110M | $102M | $99M | |
| Stock-Based Compensation | $32M | $43M | $75M | $36M | $59M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2B | $1.1B | $1.6B | $1.2B | $1.2B | |
| Capital Expenditures | $58M | $53M | $28M | $37M | $44M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.8B | -$5B | $9B | -$2.6B | -$1B | |
| Dividends Paid (Ex Special Dividend) | $239M | $366M | $356M | $367M | $361M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$327M | -- | -- | -- | -- | |
| Repurchase of Common Stock | $11M | $516M | $12M | $10M | $726M | |
| Other Financing Activities | -$12M | -$111M | -$11M | -$17M | -$119M | |
| Cash From Financing | $5.2B | $4B | -$10.9B | $1.5B | -$404M | |
| Beginning Cash (CF) | $1.3B | $1.6B | $1.8B | $1.5B | $1.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $381M | $140M | -$245M | $188M | -$194M | |
| Ending Cash (CF) | $1.6B | $1.8B | $1.5B | $1.7B | $1.5B | |
| Levered Free Cash Flow | $1.9B | $1.1B | $1.6B | $1.2B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $229M | $270M | $189M | $170M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $12M | $22M | $15M | $15M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$852M | -$83M | $403M | $70M | -- | |
| Capital Expenditures | $7M | $6M | $14M | $17M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $881M | $1.3B | $1.2B | -$135M | -- | |
| Dividends Paid (Ex Special Dividend) | $90M | $89M | $92M | $85M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -$5M | -$9M | -$57M | -- | |
| Long-Term Debt Repaid | -- | -- | $450M | $6M | -- | |
| Repurchase of Common Stock | $244M | -- | -- | $164M | -- | |
| Other Financing Activities | -$102M | -$2M | -$5M | -$104M | -- | |
| Cash From Financing | $201M | -$1.5B | -$1.3B | -$434M | -- | |
| Beginning Cash (CF) | $1.6B | $1.9B | $1.4B | $2B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $230M | -$340M | $293M | -$499M | -- | |
| Ending Cash (CF) | $1.8B | $1.5B | $1.7B | $1.5B | -- | |
| Levered Free Cash Flow | -$859M | -$89M | $389M | $53M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1B | $912M | $916M | $794M | -- | |
| Depreciation & Amoritzation | $45M | $85M | $102M | $101M | -- | |
| Stock-Based Compensation | $43M | $75M | $36M | $59M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.6B | $1.2B | $1.2B | -- | |
| Capital Expenditures | $53M | $28M | $37M | $44M | $26M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5B | $9B | -$2.6B | -$1B | -- | |
| Dividends Paid (Ex Special Dividend) | $366M | $356M | $367M | $361M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $516M | $12M | $10M | $726M | -- | |
| Other Financing Activities | -$111M | -$11M | -$17M | -$119M | -- | |
| Cash From Financing | $4B | -$10.9B | $1.5B | -$404M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $140M | -$245M | $188M | -$194M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.1B | $1.6B | $1.2B | $1.2B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1B | $912M | $916M | $794M | $467M | |
| Depreciation & Amoritzation | $30M | $28M | $26M | $25M | $43M | |
| Stock-Based Compensation | $43M | $75M | $36M | $59M | $48M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.6B | $1.2B | $1.2B | $250M | |
| Capital Expenditures | $53M | $28M | $37M | $44M | $26M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5B | $9B | -$2.6B | -$1B | -$117M | |
| Dividends Paid (Ex Special Dividend) | $366M | $356M | $367M | $361M | $259M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $497M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$351M | |
| Repurchase of Common Stock | $516M | $12M | $10M | $726M | $663M | |
| Other Financing Activities | -$111M | -$11M | -$17M | -$119M | -$8M | |
| Cash From Financing | $4B | -$10.9B | $1.5B | -$404M | $16M | |
| Beginning Cash (CF) | $6.8B | $7.4B | $5.7B | $6.8B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $140M | -$245M | $188M | -$194M | $149M | |
| Ending Cash (CF) | $7B | $7.1B | $5.9B | $6.6B | $3.2B | |
| Levered Free Cash Flow | $1.1B | $1.6B | $1.2B | $1.2B | $224M | |
Get FHN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FHN
Sector
P/E ratio
12.85x
12.32x
PEG ratio
0.33x
0.31x
P/B ratio
1.38x
1.12x
Price / LTM sales
2.48x
1.83x
Growth Metrics
FHN
Sector
Revenue growth
8.61%
5.36%
Earnings growth
76.26%
14.24%
Revenue (5-year growth)
8.85%
8.79%
Earnings forecast
$0.46
$0.64
Profitability
FHN
Sector
Profitability FY 2025
--
--
Return on invested capital
7.01%
4.96%
Return on assets
1.21%
1%
Return on equity
10.9%
9.65%
Earnings Date
Last Earnings Date
Jan
15
Next Earnings Date
Apr
15
Estimated Next Earnings Date
Apr
16
Balance Sheet
FHN
Sector
Total cash
$8.6B
$412.1M
Short term investments
$6.5B
$193.9M
Total assets
$83.9B
$3B
Long term debt
$1.3B
$75.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
